Latest filing published 28 May 2014 for Targeted Medical Pharma, Inc., €883.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William Shell discloses dealings in Targeted Medical Pharma, Inc. to SEC (Form 4). Between 8 June 2012 and 28 May 2014, the trades on record add up to 97 filings.
The open-market side counts 73 purchases for €1.2M alongside 4 sales for €68k. The net balance comes to €1.1M on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2014: no purchases and 3 sales on the market.
A typical purchase (the median) is worth €5,590.
Most recently, on 28 May 2014, the filings show an open-market sale worth €883 in Targeted Medical Pharma, Inc. The latest purchase dates back some time: it was published 4,798 days ago, on 4 September 2013. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 97 declarations